Data / Drug companies / Octinoxate, titanium dioxide, and zinc oxide
Octinoxate, titanium dioxide, and zinc oxide: 4 companies and 26 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Octinoxate, titanium dioxide, and zinc oxide is listed in the FDA National Drug Code Directory by 4 companies, with 26 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are lotion; liquid, and the newest product started marketing on September 1, 2026.
The request: Get every company that lists octinoxate, titanium dioxide, and zinc oxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 4
- Products
- 26
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- Hera Black Cushion Foundation 22N1, Hera Black Cushion Foundation 21C2, Amorepacific Color Control Cushion Compact No.106, Amorepacific Color Control Cushion Compact No.208, Even Better Glow Light Reflecting Makeup Broad Spectrum SPF 15, Hera Black Cushion Foundation 13N1, Hera Black Cushion Foundation 17C2, Hera Black Cushion Foundation 21W1
- openFDA record search
- api.fda.gov
Companies that list octinoxate, titanium dioxide, and zinc oxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amorepacific Corporation | 20 | lotion | Over the counter monograph drugs | September 1, 2026 |
| Clinique Laboratories LLC | 4 | lotion; liquid | Over the counter monograph drugs | June 25, 2020 |
| Bobbi Brown Professional Cosmetics Inc. | 1 | liquid | Over the counter monograph drugs | January 27, 2021 |
| Makeup Art Cosmetics | 1 | liquid | Over the counter monograph drugs | August 1, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lotion | 23 | 88.5% |
| Liquid | 3 | 11.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 26 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.